Evidence for increased circulating procoagulant phospholipids in patients with COVID-19 pneumonia and their prognostic role

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry and laboratory medicine 2021-02, Vol.59 (2), p.53-55
Hauptverfasser:	Assimakopoulos, Stelios F., Emmanuil, Andreas, Tsimeka, Asimina, Chalkidi, Theodora, Marangos, Markos, Gogos, Charalambos
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - therapeutic use Blood Coagulation - drug effects Blood Coagulation Factors - analysis C-Reactive Protein - analysis COVID-19 COVID-19 - blood Disease Progression Female Ferritins - analysis Heparin, Low-Molecular-Weight - therapeutic use Humans Male microparticles Middle Aged Phospholipids Phospholipids - blood procoagulant phospholipids Prognosis Prospective Studies Pulmonary Embolism - prevention & control SARS-CoV-2 thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!